Does mesalamine protect against colorectal cancer in inflammatory bowel disease?
Aminosalicylate and folic acid use may decrease the risk of CRC among IBD patients.
In this tumor model, HT enhanced the antitumor effect of cDDP. Previous radiation treatment did not reduce the HT-enhanced effect of cDDP. Combined cDDP and HT may be useful in the treatment of nonirradiated tumors as well as previously irradiated tumors.